全文获取类型
收费全文 | 182336篇 |
免费 | 34622篇 |
国内免费 | 2574篇 |
专业分类
耳鼻咽喉 | 5493篇 |
儿科学 | 6410篇 |
妇产科学 | 3211篇 |
基础医学 | 7726篇 |
口腔科学 | 2999篇 |
临床医学 | 29768篇 |
内科学 | 54072篇 |
皮肤病学 | 8165篇 |
神经病学 | 17947篇 |
特种医学 | 7127篇 |
外国民族医学 | 1篇 |
外科学 | 44023篇 |
综合类 | 442篇 |
现状与发展 | 72篇 |
一般理论 | 43篇 |
预防医学 | 11136篇 |
眼科学 | 3787篇 |
药学 | 3121篇 |
1篇 | |
中国医学 | 127篇 |
肿瘤学 | 13861篇 |
出版年
2024年 | 716篇 |
2023年 | 5189篇 |
2022年 | 2112篇 |
2021年 | 4632篇 |
2020年 | 6953篇 |
2019年 | 3499篇 |
2018年 | 8808篇 |
2017年 | 8346篇 |
2016年 | 9512篇 |
2015年 | 9574篇 |
2014年 | 17026篇 |
2013年 | 17509篇 |
2012年 | 8342篇 |
2011年 | 8418篇 |
2010年 | 11872篇 |
2009年 | 15460篇 |
2008年 | 7681篇 |
2007年 | 5896篇 |
2006年 | 8120篇 |
2005年 | 5231篇 |
2004年 | 4253篇 |
2003年 | 3025篇 |
2002年 | 2989篇 |
2001年 | 4131篇 |
2000年 | 3335篇 |
1999年 | 3472篇 |
1998年 | 3793篇 |
1997年 | 3595篇 |
1996年 | 3477篇 |
1995年 | 3327篇 |
1994年 | 2028篇 |
1993年 | 1647篇 |
1992年 | 1495篇 |
1991年 | 1521篇 |
1990年 | 1168篇 |
1989年 | 1257篇 |
1988年 | 1112篇 |
1987年 | 947篇 |
1986年 | 964篇 |
1985年 | 783篇 |
1984年 | 631篇 |
1983年 | 577篇 |
1982年 | 574篇 |
1981年 | 448篇 |
1980年 | 401篇 |
1979年 | 350篇 |
1978年 | 369篇 |
1977年 | 425篇 |
1975年 | 301篇 |
1972年 | 326篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
Introduction: Cutaneous T-cell lymphomas (CTCL) are rare non-Hodgkin lymphomas of skin-homing T-cells that initially or mainly manifest cutaneously. Treatment of CTCL is challenging given the disease states’ varying presentation and prognosis. Systemic treatment options often lack comparative evidence and have relatively low response rates and short duration of response. The recent Food and Drug Administration (FDA) approval of mogamulizumab in adult patients with relapsed or refractory (R/R) CTCL after at least one prior line of therapy provided a new treatment option to patients with advanced disease.
Areas covered: The authors discuss basic information about CTCL and mogamulizumab’s mechanism of action. Then, the authors discuss the agent’s efficacy. Finally, the authors evaluate the safety of mogamulizumab in comparison to other agents available in CTCL.
Expert opinion: Mogamulizumab has been shown to be an effective and well tolerated therapy for patients with relapsed and refractory MF/SS with excellent activity in the circulating component of the disease. 相似文献
92.
93.
94.
95.
96.
97.
98.
99.
Thaís dos Santos Fontes Pereira Carolina Cavalieri Gomes Peter A Brennan Felipe Paiva Fonseca Ricardo Santiago Gomez 《Journal of oral pathology & medicine》2019,48(1):3-9
Fibrous dysplasia is a non‐neoplastic developmental process that affects the craniofacial bones, characterized by painless enlargement as a result of bone substitution by abnormal fibrous tissue. Postzygotic somatic activating mutations in the GNAS1 gene cause fibrous dysplasia and have been extensively investigated, as well as being helpful in the differential diagnosis of the disease. Fibrous dysplasia may involve one (monostotic) or multiple bones (polyostotic), sporadically or in association with McCune‐Albright syndrome, Jeffe‐Lichenstein syndrome, or Mazabreud syndrome. This review summarizes the current knowledge on fibrous dysplasia, emphasizing the value of integrating the understanding of its molecular pathogenesis with the clinical, radiological, and histopathological features. In addition, we address important aspects related to the differential diagnosis and patient management. 相似文献
100.
David Simon Koray Tascilar Sara Unbehend Sara Bayat Andreas Berlin Anna-Maria Liphardt Timo Meinderink Juergen Rech Axel J Hueber Georg Schett Arnd Kleyer 《Journal of bone and mineral research》2020,35(9):1695-1702
The impact of primary hand osteoarthritis (HOA) on bone mass, microstructure, and biomechanics in the affected skeletal regions is largely unknown. HOA patients and healthy controls (HCs) underwent high-resolution peripheral quantitative computed tomography (HR-pQCT). We measured total, trabecular, and cortical volumetric bone mineral densities (vBMDs), microstructural attributes, and performed micro–finite element analysis for bone strength. Failure load and scaled multivariate outcome matrices from distal radius and second metacarpal (MCP2) head measurements were analyzed using multiple linear regression adjusting for age, sex, and functional status and reported as adjusted Z-score differences for total and direct effects. A total of 105 subjects were included (76 HC: 46 women, 30 men; 29 HOA: 23 women, six men). After adjustment, HOA was associated with significant changes in the multivariate outcome matrix from the MCP2 head (p < .001) (explained by an increase in cortical vBMD (Δz = 1.07, p = .02) and reduction in the trabecular vBMD (Δz = −0.07, p = .09). Distal radius analysis did not show an overall effect of HOA; however, there was a gender-study group interaction (p = .044) explained by reduced trabecular vBMD in males (Δz = −1.23, p = .02). HOA was associated with lower failure load (−514 N; 95%CI, −1018 to −9; p = 0.05) apparent in males after adjustment for functional status. HOA is associated with reduced trabecular and increased cortical vBMD in the MCP2 head and a reduction in radial trabecular vBMD and bone strength in males. Further investigations of gender-specific changes of bone architecture in HOA are warranted. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. 相似文献